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Abstract
This chapter describes contemporary strategies for selective catalytic inter-
molecular functionalization of the benzimidazole scaffold. Functionalization at 
nitrogen and position C-2 is well developed employing copper, palladium, rhodium, 
nickel, and cobalt catalysis. Direct CH activation is the predominant approach to 
C-2 functionalization. Nickel-based catalysts can activate C—O bonds in conjunc-
tion with C—H activation at benzimidazole which grants access to a very broad 
range of phenols and enols as convenient functionalization precursors in this 
chemistry. The remaining carbon positions of benzimidazoles are typically func-
tionalized via a sequential halogenation/coupling strategy to ensure selectivity. A 
key success factor in enabling these chemistries has been the fine-tuning of catalyst-
ligand combinations.
Keywords: benzimidazoles, catalysis, C—H activation, cross-coupling, late-stage 
functionalization
1. Introduction
Benzimidazoles are tremendously important heterocycles in chemistry. They 
play a vital part in modern medicinal chemistry due to the importance of the 
benzimidazole as a pharmacophore in natural products and pharmaceuticals [1]. 
Benzimidazoles have a central role in contemporary homogeneous catalysis, par-
ticularly as ligands in metal catalysis and as a source of N-heterocyclic carbenes [2]. 
Moreover, they are important components of organic materials, e.g., optoelectronic 
materials [3]. Thus, the generation of a broad range of structurally diverse benz-
imidazoles is of paramount importance for enabling novel applications and unique 
properties to emerge.
Substituted benzimidazoles are typically synthesized de novo using a range of 
methods [1]. This is by far the most common approach, and new methods emerge 
steadily [4]. However, large libraries of benzimidazoles are needed in medicinal 
chemistry, catalysis, and materials science in order to discover fine-tuned proper-
ties and to optimize these. Thus, de novo synthesis makes for a rather inefficient 
approach since the benzimidazole scaffold must be constructed for each new 
analogue needed. A more powerful strategy would be to start with available benz-
imidazoles and be able to do functionalization with desired groups directly onto the 
scaffold—so-called late-stage functionalization [5].
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In this chapter the current catalytic strategies and methods for the intermolecu-
lar functionalization of benzimidazoles will be presented. These are surprisingly 
few, which illustrates the complexity involved when trying to selectively functional-
ize specific positions in the scaffold (Figure 1). The current strategies to solve this 
problem, and thus greatly streamline the synthesis of substituted benzimidazoles, 
will be presented herein with selected examples appearing since around 2003. 
We consider only catalytic strategies for intermolecular functionalization and aim 
to provide a good overview of state of the art in late-stage functionalization of 
benzimidazoles.
2. Catalytic functionalization chemistry
2.1 N-functionalization
Functionalization at nitrogen is perhaps the most straightforward. Classical 
bimolecular substitution can be used to alkylate in the presence of suitable bases. 
Nucleophilic aromatic substitutions or Ullmann couplings give rise to a number of 
N-arylated heterocycles, albeit with major limitations [1]. In recent years, catalytic 
methods and more sophisticated reaction conditions facilitate arylation and alkyla-
tion of this position with groups unavailable via classical chemistry [6].
A selectivity issue must be mentioned for unsymmetrical benzimidazoles with 
a free N—H. There is a rapid tautomeric equilibrium in which the proton shuffles 
between the two nitrogen sites. Thus, a particular tautomer must be “locked” in 
advance of the functionalization by substitution in order to obtain one distinct isomer.
Shieh and co-workers have reported an effective 1,4-diazabicyclo[2.2.2]octane 
(DABCO)-catalyzed N-benzylation reaction using dibenzyl carbonate (2) in the 
presence of a stoichiometric amount of the ionic liquid tetraoctyl ammonium 
bromide (Figure 2) [7]. The ionic liquid had a dramatic effect on both the reaction 
rate and yield, and the model benzylation of benzimidazole (1) afforded excellent 
95% yield of 3.
Buchwald et al. have reported one of the most general catalytic systems for 
efficient and mild N-arylations of benzimidazoles 4 (Figure 3) [8]. The bidentate 
ligand 6 in combination with dimethyl sulfoxide (DMSO) as solvent enabled this 
copper(I)-catalyzed coupling to occur even with unactivated aryl bromides 5 and 
afford 2-substituted benzimidazoles 7 in 71–98% yields. Notably, the coupling is 
also efficient with ortho-substituted aryl bromides.
The authors propose a mechanism for this transformation initiated by 
N-coordination of the benzimidazole to a Cu(I)Br-6 complex followed by deprot-
onation of the N—H by the base. Subsequent oxidative addition of the aryl bromide 
to generate a cationic Cu(II) intermediate followed by reductive elimination 
releases the N-arylated benzimidazole 7 and regenerates the active Cu(I) catalyst. 
The method appears general and is a powerful tool for direct N-arylation of benz-
imidazoles [8].
Figure 1. 
The benzimidazole scaffold and its functionalization sites.
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Bao et al. have reported practical copper-catalyzed methods for N-vinylation 
[9]. In the most practical version, employing copper(I) oxide in the presence of 
a β-ketoester ligand precursor, they were able to couple electronically diverse 
E-bromostyrenes 8 with benzimidazole 1 to generate N-vinylated products 9 in 
54–91% yields (Figure 4). Notably, the products retained the E-stereochemistry in 
the reaction with excellent >95:5 selectivity.
2.2 Functionalization at C-2
Catalytic functionalization at position C-2 is by far the most predominant in the 
literature. This is likely due to the more reactive nature of this particular C—H bond 
as it is situated between the two electron-withdrawing nitrogen sites. Although pal-
ladium, nickel, and rhodium play the major roles in this chemistry, some examples 
of copper-catalyzed C-2 functionalization exist. For example, copper(II) acetate 
in the presence of air has been employed for oxidative couplings of benzimidazoles 
at C-2 [10]. Furthermore, one exciting example of a copper(I) iodide (10 mol%)-
catalyzed arylation with iodobenzene at C-2 of N-methylbenzimidazole was 
reported by Daugulis et al. to proceed in 89% yield [11]. Despite these promising 
results, there are no extensive studies of copper-catalyzed functionalizations at C-2 
of benzimidazoles in particular.
2.2.1 Arylation and vinylation
An early example of palladium-catalyzed C-2 arylation by Bellina and Rossi 
involves the coupling of aryl iodides 10 with benzimidazole 1 under ligandless and 





Chemistry and Applications of Benzimidazole and its Derivatives
4
superstoichiometric amount of copper(I) iodide in dimethylformamide (DMF) at 
high temperatures to afford 2-arylbenzimidazoles 11 in high purities and 81–89% 
yields. This demonstrated for the first time the possibility of using base-sensitive, 
unprotected N—H containing heterocycles without prior protection in this chem-
istry. A major drawback of the ligandless approach is relatively long reaction times 
(>48 hrs) at elevated temperatures in addition to the large amounts of copper(I) 
salt needed [12] (Figure 5).
The contemporary power of palladium-catalyzed coupling chemistry lies in 
ligand design [13]. The size and nature of the ligand play a crucial role in determin-
ing the possible pathways, selectivity, and kinetics, and, as such, optimization of 
ligand structure to suit the needs of the desired coupling reaction is key to modern 
catalytic reaction design. The number of ligands with vast spread in electronic 
and steric properties for palladium catalysis available today is large and expand-
ing rapidly. This area lies at the forefront of modern catalysis research in organic 
chemistry [14].
A major step forward from the ligandless C-2 arylation reported above is the 
C—H arylation of N-substituted benzimidazoles 12 and aryl/heteroaryl chlorides 
13 in the presence of the well-defined N-heterocyclic carbene-imidazole catalyst 14 
(Figure 6). The reaction afforded moderate to good yields (56–97%) of a variety of 
C-2-arylated benzimidazoles 15 [15].
The first Ni-catalyzed C—H arylation and vinylation at C-2 of benzimidazoles 
were reported by Itami et al. in 2015 [16]. A major advance in the chemistry was the 
use of carbamate derivatives of phenols (16) or enols (17) as the source of aryl and 
vinyl groups, respectively (Figure 7). The catalytic system consists of nickel(II) 
triflate with potassium phosphate as base and bis-phosphine ligands; the latter are 
crucial. The use of a tertiary alcohol (AmylOH) as solvent was also crucial for this 
chemistry. 1,2-Bis(dicyclohexylphosphino)ethane (dcype) was the optimal ligand 




Early Pd-catalyzed C-2 arylation under ligandless conditions.
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yield. This catalytic system could also facilitate arylations with aryl chlorides (13) in 
64–86% yield. The potential synthetic power of this arylation approach was dem-
onstrated by performing a functionalization of the nonsteroidal anti-inflammatory 
drug indomethacin with N-methylbenzimidazole at the chlorine site (26% yield). A 
different ligand, 1,2-bis(dicyclohexylphosphino)thiophene (dcypt), was employed 
as the optimal to achieve efficient C-2 vinylations with enol derivatives (17) to 
afford 2-vinylbenzimidazoles 18 in 29–87% yields [16].
The proposed mechanism for the nickel(II)-catalyzed approach involves 
reduction to a nickel(0) species by action of the bisphosphines or benzimidazole 
Figure 6. 
Pd-catalyzed C-2 arylation with aryl chlorides.
Figure 7. 
Ni-catalyzed arylation and vinylation by domino C—H/C—O activation.
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to initiate a Ni(0)–Ni(II) catalytic cycle [16]. Oxidative addition of the carbamate 
aryl C—O bond onto the activated Ni(0)-bisphosphine complex followed by C—H 
nickelation assisted by departure of the corresponding carbamic acid generates a 
key intermediate for reductive elimination of the product and regeneration of the 
active Ni(0) species [16].
The ability of nickel to undergo C—O activation enables the use of a range of 
practical and available substrates for functionalization. Wang and co-workers 
have recently disclosed C-2 arylations of benzimidazoles using methoxyarenes 
as functionalization agents in the presence of Grignard reagents [17]. Thus, the 
reaction system effects tandem C—O/C—H activation with subsequent coupling. 
The Grignard reagent was critical in order to minimize nonproductive couplings. 
A major demonstration of the applicability of this method is the reaction between 
steroidal hormone β-estradiol methoxy derivative 19 and N-methylbenzimidazole 
which afforded the C-2 steroid-functionalized benzimidazole 20 in very good 74% 
yield (Figure 8). The selectivity of aromatic methoxy group activation is striking, 
as the aliphatic methoxy group is left intact. The unusual dicarbene ligand carbodi-
carbene (CDC) was crucial for this reactivity and also demonstrates the importance 
of benzimidazoles as components of ligands for transition metal catalysis [17].
C-2 vinylation with alkynes as functionalization reagents has been reported, 
and these reactions occur under mild conditions with nickel or cobalt complexes 
in the presence of phosphine ligands. In a nickel-catalyzed process reported by 
Nakao et al., N-methylbenzimidazole reacts with internal alkynes to afford the 
C-2 vinylated products in 80–92% yields [18]. The cobalt-catalyzed vinylation of 
N-pyrimidylbenzimidazole 21 with alkyne 22 affords vinylation product 23 in 82% 
yield (Figure 9) in the presence of the phosphine ligand 2-[2-(diphenylphosphanyl)
ethyl]pyridine (pyphos) and an equivalent of a Grignard reagent in tetrahydrofuran 
(THF) at ambient temperatures [19]. The N-pyrimidyl group is required for direct-
ing the chemistry to the C-2 site but can be easily removed from the scaffold after 
functionalization.
2.2.2 Alkylation
In the area of catalytic C-2 alkylations, rhodium(I) and nickel(0) complexes 
play a major role. Rhodium(I)-catalyzed linear C-2 alkylation was reported first 
by Bergman and Ellman [20]. In 2012, Shih et al. reported alkylations with full 
Figure 8. 
Complex Ni-catalyzed C-2 arylation with estradiol dimethyl ether.
7
Catalytic Intermolecular Functionalization of Benzimidazoles
DOI: http://dx.doi.org/10.5772/intechopen.87068
control of linear versus branched selectivity using AlMe3 as a chemical switch 
(Figure 10) [21]. In the presence of 10 mol% of Ni(cod)2 (cod = cyclooctadiene) 
and the bidentate N-heterocyclic carbene (NHC) ligand 24 in toluene, the reaction 
between N-methylbenzimidazole and substituted styrenes 25 afforded exclusively 
branched alkylation products 26 in 50–98% yields. The addition of 10 mol% of 
AlMe3 completely switched the selectivity toward linear alkylation products 27 
in 55–99% yields. The branched product is electronically favored, but the linear 
product arises in the presence of AlMe3 because the benzimidazole nitrogen at 
position 3 will generate a Lewis acid/base adduct causing a steric switch in the 
preferred binding orientation of the styrene during the catalytic cycle. Thus, the 
linear product is formed predominantly [21].
Obtaining branched selectivity in C-2 alkylations has been one of the major 
challenges in this chemistry, and the above example is the only report appearing 
before 2017 demonstrating this. As is often the case, fine-tuned selectivity control 
can be a matter of discovering fine-tuned ligand properties. Thus, Tran and Ellman 
recently reported a rhodium(I)-catalyzed C-2 alkylation of benzimidazoles 28 
using acrylic systems 29 in the presence of the bidentate phosphine ligand dArFpe 
Figure 9. 
A Co-catalyzed C-2 vinylation with alkynes.
Figure 10. 
AlMe3 as a chemical switch for branched vs. linear alkylations at C-2.
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yielding exclusively branched alkylation products 30 in 12–96% yields (Figure 11) 
[22]. The use of ethyl methacrylate afforded products with a quaternary carbon at 
the C-2 site. The amide group can easily be converted to an aldehyde, thus making 
these products useful building blocks in medicinal chemistry.
2.3 Functionalization at C-4/C-7
Catalytic functionalizations at positions 1–3 are rather common in benzimid-
azoles. The activated nature of these positions makes direct functionalization 
chemistry feasible with a variety of catalytic systems as surveyed in Sections 2.1 
and 2.2. Selective catalytic functionalization at positions 4–7 is significantly more 
challenging since these positions are less activated and also less chemically distin-
guishable from each other. Benzimidazoles that are pre-functionalized with some 
reactive functional group (mostly halogens), generated by de novo synthesis, are 
commonly used to achieve selectivity in these cases.
In order to obtain a key monomer for the construction of crystalline covalent 
organic frameworks (COFs), Xu et al. reported the double functionalization of 
4,7-dibromobenzimidazole 31 using a Suzuki-Miyaura approach (Figure 12) [23]. 
Under rather standard cross-coupling conditions with 10 mol% of palladium(0) 
tetrakistriphenylphosphine and two equivalents of pinacol boronic ester 32, double 
functionalization was achieved in 90% yield [23]. This is an example of the utility 
of benzimidazole functionalization in materials chemistry.
A great example of the utility of benzimidazole functionalization at C-4/C-7 in 
medicinal chemistry was reported by Auberson et al. in 2015 [24]. The 4-bromo-
6-carbomethoxybenzimidazole 33 was treated with bisboronic ester 34 under cata-
lytic action of Pd(dppf)Cl2 (dppf = 1,1′-ferrocenediyl-bis(diphenylphosphine)), 
which afforded 92% yield of the boronic acid 35 (Figure 13). 35 was next employed 
as a coupling partner in a Suzuki-Miyaura coupling with heterocyclic bromide 36 
to afford the complex product 37 in 77% yield [24]. This demonstrates an interest-
ing strategy in which an accessible bromobenzimidazole can be transformed into a 
Figure 11. 
Rh(I)-catalyzed branched alkylation at C-2.
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boronic acid for cross-coupling chemistry. Thus, it is overall a cross-coupling of two 
aryl bromides, really harnessing the full power of palladium catalysis.
Another powerful cross-coupling transformation of aryl halides is the 
Buchwald-Hartwig amination. The selective formation of C—N bonds clearly has 
numerous applications in medicinal chemistry. De la Fuente et al. have reported 
Buchwald-Hartwig functionalization with N-tert-butoxycarbonyl (Boc)-protected 
piperazine at position 4 of 4-chlorobenzimidazole 38 in the presence of Pd2dba3 
and a phosphine ligand P(tBu)3 (Figure 14) [25]. The [2-(trimethylsilyl)ethoxy]
methyl acetal (SEM) protecting group at nitrogen was installed indiscriminately at 
Figure 12. 
Double Suzuki-Miyaura coupling to generate COF monomer.
Figure 13. 
Complex C-4 functionalization via borylation-cross-coupling sequence.
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the two nitrogen sites, so the starting material was effectively a 1:1 mixture of the 
4- and 7-chlorobenzimidazole. However, the desired isomer was the 4-piperazinyl-
benzimidazole 39 which could be isolated in a very good 43–49% yield (50% is 
theoretical maximum yield of one isomer) [25].
2.4 Functionalization at C-5 and C-6
Although most reported halogenated benzimidazoles are generated by de novo 
synthesis, in which the halogen is pre-functionalized on the starting materials used 
for assembling the benzimidazole scaffold, some examples exist of selective cata-
lytic halogenations directly onto benzimidazole.
A practical and selective monobromination at C-5 has been reported by Das 
et al. in which sulfonic-acid functionalized silica acts as a heterogeneous acid 
catalyst system [26]. With only 13 wt% catalyst in the presence of an equivalent of 
N-bromosuccinimide (NBS), 77% yield of 5-bromobenzimidazole 40 was observed 
(Figure 15). Although the catalyst system is heterogeneous, its reactive Brønsted 
acidic sites are highly mobile on the catalyst surface and therefore achieve efficiency 
similar to that of homogeneous catalysts. Moreover, the catalyst could be recycled 
up to three times without loss of activity. The above study is interesting, particularly 
since no C-2 bromination was observed [26]. An early study by Smith et al. also 
used NBS as a brominating agent, but in the presence of pure silica gel acting as the 
heterogeneous catalyst, which yielded C-2 bromination only (67% yield), unless 
this position was occupied. They predominantly achieved C-2/C-5 dibromination 
when using two equivalents of NBS (60% yield) [27].
Cui et al. report a strategy for iodination at C-6 of 41 involving a pre-installed 
C-6 bromo substituent (Figure 16) [28]. By using a Pd(0)-catalyzed stannylation 
reaction, the C-6 tributyltin-substituted benzimidazole 42 can be generated albeit 
in low yields (14–29%). These products can further undergo oxidative iodination 
in the presence of molecular iodine in low to moderate yields (27–47% yields). The 
method was applied to radioiodination at C-6 with 125-I derived from [125I]NaI 
under oxidative conditions and afforded 43% radiochemical yield of the desired 
labeled product [28].
The strategy of bromination/Pd-catalyzed coupling has been employed for 
installment of various groups at positions C-5/C-6 in benzimidazoles. However, 
many are described only in the patent literature which often presents little informa-
tion about conditions and chemical yields. Notably, this strategy has been employed 
for regioselective cyanation and carboxylation [29], alkylation (Negishi coupling) 
Figure 14. 
Buchwald-Hartwig amination functionalization at C-4.
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[30], alkynylation (Hiyama coupling) [31], and heteroarylation (Suzuki-Miyaura 
coupling) [32], thus demonstrating that a variety of combinations of halogens and 
cross-coupling chemistries are possible for synthesis of diverse benzimidazoles.
3. Conclusions
The need for new benzimidazoles with unique appendages and well-defined 
regioselectivity is undeniable from the viewpoints of medicinal and materials 
chemistry. The numerous applications, some of which are described herein, warrant 
further studies into the synthesis of novel analogues. This chapter has described 
the role of state-of-the-art catalytic chemistry in intermolecular functionalization 
of de novo assembled benzimidazole scaffolds. Particularly well developed are 
functionalizations at nitrogen and at position C-2 in the scaffold. N-Arylation and 
vinylations are effectively mediated by copper catalysts, whereas C-2 functional-
ization can be affected by a wider spectrum of palladium, rhodium, nickel, and 
cobalt catalysts involving direct C—H activation chemistry. A key success factor 
in enabling these chemistries has been the fine-tuning of ligand properties in the 
various catalytic systems. Functionalization of positions C-4 through C-7 is more 
challenging as these are less activated and less chemically distinguishable, so the use 
of pre-functionalization by de novo installment of halogens followed by contempo-
rary cross-coupling chemistries is the most successful strategy to date. Even more 
Figure 15. 
Heterogeneously catalyzed C-5 bromination by functionalized silica.
Figure 16. 
Pd-catalyzed stannylation and subsequent radioiodination at C-5/C-6.
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powerful methods are anticipated to emerge in this area to make these positions also 
available for selective late-stage functionalization through direct C—H activation.
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